Variant report
Variant | esv3411201 |
---|---|
Chromosome Location | chr13:86184051-86187349 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546742907 | chr13:86184074-86184075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201576264 | chr13:86184089-86184090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567003478 | chr13:86184106-86184107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9602781 | chr13:86184136-86184137 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs550645002 | chr13:86184138-86184139 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574762794 | chr13:86184146-86184147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs373718435 | chr13:86184156-86184157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569051646 | chr13:86184170-86184171 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs597354 | chr13:86184204-86184205 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs545575751 | chr13:86184270-86184271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554545873 | chr13:86184274-86184275 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573442453 | chr13:86184283-86184284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534239913 | chr13:86184286-86184287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35435621 | chr13:86184334-86184335 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183133627 | chr13:86184349-86184350 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113254552 | chr13:86184357-86184358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564246629 | chr13:86184405-86184406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575590990 | chr13:86184430-86184431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186459009 | chr13:86184449-86184450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374954483 | chr13:86184573-86184574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34737505 | chr13:86184615-86184616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558953806 | chr13:86184616-86184617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563360279 | chr13:86184645-86184646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190844940 | chr13:86184682-86184683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144858332 | chr13:86184748-86184749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182606474 | chr13:86184754-86184755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560740111 | chr13:86184767-86184768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370588353 | chr13:86184771-86184772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528361752 | chr13:86184813-86184814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186944165 | chr13:86184814-86184815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374240935 | chr13:86184833-86184834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369407275 | chr13:86184871-86184872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192503528 | chr13:86184982-86184983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:86182200-86184400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr13:86183400-86184800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr13:86183600-86184400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr13:86184800-86185000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |